Evidence map›Paper›PMID 37292483›Full record

ArticleArXiv2023

Machine Learning for Protein Engineering.

Kadina E Johnston, Clara Fannjiang, Bruce J Wittmann, Brian L Hie, Kevin K Yang, Zachary Wu

Open access · greenAbstract readPreprint
In one paragraph

Article in ArXiv, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 21 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Kadina E JohnstonCalifornia Institute of Technology.
Clara FannjiangUniversity of California, Berkeley.
Bruce J Wittmannwork done while at California Institute of Technology, now at Microsoft.
Brian L HieStanford University.
Kevin K YangMicrosoft Research New England.
Zachary Wu
California Institute of Technology · USDeepMind (United Kingdom) · GBMicrosoft (United States) · USStanford University · USUniversity of California, Berkeley · US

Funding

Predoctoral Biotechnology Leadership Training in Micro/NanomedicineT32GM112592 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H · 2015 to 2019
$1.1M
NIGMS NIH HHS T32 GM112592
6 · The paper itself

Abstract

Directed evolution of proteins has been the most effective method for protein engineering. However, a new paradigm is emerging, fusing the library generation and screening approaches of traditional directed evolution with computation through the training of machine learning models on protein sequence fitness data. This chapter highlights successful applications of machine learning to protein engineering and directed evolution, organized by the improvements that have been made with respect to each step of the directed evolution cycle. Additionally, we provide an outlook for the future based on the current direction of the field, namely in the development of calibrated models and in incorporating other modalities, such as protein structure.

Identifiers

PMID37292483
PMCPMC10246115
OpenAlexW4378711548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.